ID   HNRH1_HUMAN             Reviewed;         449 AA.
AC   P31943; B3KW86; D3DWQ2; Q6IBM4;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   07-APR-2021, entry version 220.
DE   RecName: Full=Heterogeneous nuclear ribonucleoprotein H;
DE            Short=hnRNP H;
DE   Contains:
DE     RecName: Full=Heterogeneous nuclear ribonucleoprotein H, N-terminally processed;
GN   Name=HNRNPH1; Synonyms=HNRPH, HNRPH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 180-184; 193-197 AND
RP   200-230.
RX   PubMed=7499401; DOI=10.1074/jbc.270.48.28780;
RA   Honore B., Rasmussen H.H., Vorum H., Dejgaard K., Liu X., Gromov P.,
RA   Madsen P., Gesser B., Tommerup N., Celis J.E.;
RT   "Heterogeneous nuclear ribonucleoproteins H, H', and F are members of a
RT   ubiquitously expressed subfamily of related but distinct proteins encoded
RT   by genes mapping to different chromosomes.";
RL   J. Biol. Chem. 270:28780-28789(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-14; 17-44; 50-68; 82-114; 151-167; 180-185; 233-259;
RP   276-294; 300-347 AND 356-375, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION
RP   AT MET-1 AND MET-2, METHYLATION AT ARG-233, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=B-cell lymphoma, Cervix carcinoma, Hepatoma, Lung carcinoma,
RC   Mammary carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Boldt K., von Kriegsheim A., Matallanas D., Cooper W.N.,
RA   Calvo F., Kolch W., Vousden K.H., Lukashchuk N., Lilla S., Lempens A.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 2-14; 17-29; 88-114; 151-167; 263-275; 300-347;
RP   344-375; 377-386; 418-432; 473-483 AND 542-553, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 127-135 AND 153-163.
RX   PubMed=7512260; DOI=10.1093/nar/22.6.1059;
RA   Matunis M.J., Xing J., Dreyfuss G.;
RT   "The hnRNP F protein: unique primary structure, nucleic acid-binding
RT   properties, and subcellular localization.";
RL   Nucleic Acids Res. 22:1059-1067(1994).
RN   [9]
RP   PROTEIN SEQUENCE OF 200-230.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH PTBP1; PTBP2 AND FUBP2.
RX   PubMed=11003644; DOI=10.1128/mcb.20.20.7463-7479.2000;
RA   Markovtsov V., Nikolic J.M., Goldman J.A., Turck C.W., Chou M.-Y.,
RA   Black D.L.;
RT   "Cooperative assembly of an hnRNP complex induced by a tissue-specific
RT   homolog of polypyrimidine tract binding protein.";
RL   Mol. Cell. Biol. 20:7463-7479(2000).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE SPLICEOSOMAL
RP   C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/s1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-246, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   FUNCTION, INTERACTION WITH CUGBP1 AND MBNL1, RNA-BINDING, AND INDUCTION.
RX   PubMed=16946708; DOI=10.1038/sj.emboj.7601296;
RA   Paul S., Dansithong W., Kim D., Rossi J., Webster N.J., Comai L., Reddy S.;
RT   "Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated
RT   aberrant IR splicing.";
RL   EMBO J. 25:4271-4283(2006).
RN   [15]
RP   INTERACTION WITH IGF2BP1.
RX   PubMed=17289661; DOI=10.1074/mcp.m600346-mcp200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND MET-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND SER-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND MET-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-54 AND SER-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-233, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-35; LYS-87 AND LYS-98, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: This protein is a component of the heterogeneous nuclear
CC       ribonucleoprotein (hnRNP) complexes which provide the substrate for the
CC       processing events that pre-mRNAs undergo before becoming functional,
CC       translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative
CC       splicing regulation. Inhibits, together with CUGBP1, insulin receptor
CC       (IR) pre-mRNA exon 11 inclusion in myoblast. Binds to the IR RNA. Binds
CC       poly(RG). {ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:16946708}.
CC   -!- SUBUNIT: Part of a ternary complex containing FUBP2, PTBP1, PTBP2 and
CC       HNRNPH1. Identified in the spliceosome C complex. Interacts with
CC       IGF2BP1. Interacts with CUGBP1; the interaction is RNA-dependent.
CC       Interacts with MBNL1; the interaction in RNA-independent.
CC       {ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:11991638,
CC       ECO:0000269|PubMed:16946708, ECO:0000269|PubMed:17289661}.
CC   -!- INTERACTION:
CC       P31943; Q5VV41: ARHGEF16; NbExp=3; IntAct=EBI-351590, EBI-1057448;
CC       P31943; Q8NEC5: CATSPER1; NbExp=3; IntAct=EBI-351590, EBI-744545;
CC       P31943; Q96HB5: CCDC120; NbExp=3; IntAct=EBI-351590, EBI-744556;
CC       P31943; O75909-2: CCNK; NbExp=3; IntAct=EBI-351590, EBI-12010594;
CC       P31943; Q92841: DDX17; NbExp=3; IntAct=EBI-351590, EBI-746012;
CC       P31943; Q86Y13: DZIP3; NbExp=3; IntAct=EBI-351590, EBI-948630;
CC       P31943; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-351590, EBI-744099;
CC       P31943; O95872: GPANK1; NbExp=3; IntAct=EBI-351590, EBI-751540;
CC       P31943; Q13227: GPS2; NbExp=3; IntAct=EBI-351590, EBI-713355;
CC       P31943; P52597: HNRNPF; NbExp=3; IntAct=EBI-351590, EBI-352986;
CC       P31943; P31943: HNRNPH1; NbExp=3; IntAct=EBI-351590, EBI-351590;
CC       P31943; P52272: HNRNPM; NbExp=3; IntAct=EBI-351590, EBI-486809;
CC       P31943; Q52LG2: KRTAP13-2; NbExp=3; IntAct=EBI-351590, EBI-11953846;
CC       P31943; P25800: LMO1; NbExp=3; IntAct=EBI-351590, EBI-8639312;
CC       P31943; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-351590, EBI-11742507;
CC       P31943; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-351590, EBI-739832;
CC       P31943; Q9Y5V3: MAGED1; NbExp=3; IntAct=EBI-351590, EBI-716006;
CC       P31943; Q9NR56: MBNL1; NbExp=2; IntAct=EBI-351590, EBI-2805004;
CC       P31943; Q96EL3: MRPL53; NbExp=3; IntAct=EBI-351590, EBI-2513715;
CC       P31943; Q96DH6: MSI2; NbExp=3; IntAct=EBI-351590, EBI-2462339;
CC       P31943; Q86VE0: MYPOP; NbExp=3; IntAct=EBI-351590, EBI-2858213;
CC       P31943; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-351590, EBI-10271199;
CC       P31943; Q9BRJ7: NUDT16L1; NbExp=3; IntAct=EBI-351590, EBI-2949792;
CC       P31943; Q8TDS5: OXER1; NbExp=3; IntAct=EBI-351590, EBI-12813389;
CC       P31943; Q9HBE1-4: PATZ1; NbExp=6; IntAct=EBI-351590, EBI-11022007;
CC       P31943; P50542-3: PEX5; NbExp=3; IntAct=EBI-351590, EBI-12181987;
CC       P31943; O15160: POLR1C; NbExp=4; IntAct=EBI-351590, EBI-1055079;
CC       P31943; Q7Z5V6-2: PPP1R32; NbExp=3; IntAct=EBI-351590, EBI-12000762;
CC       P31943; Q9BTL3: RAMAC; NbExp=3; IntAct=EBI-351590, EBI-744023;
CC       P31943; O43251-10: RBFOX2; NbExp=3; IntAct=EBI-351590, EBI-11963050;
CC       P31943; Q9H0Z9: RBM38; NbExp=3; IntAct=EBI-351590, EBI-2840723;
CC       P31943; P78317: RNF4; NbExp=3; IntAct=EBI-351590, EBI-2340927;
CC       P31943; P14678-2: SNRPB; NbExp=3; IntAct=EBI-351590, EBI-372475;
CC       P31943; P09234: SNRPC; NbExp=3; IntAct=EBI-351590, EBI-766589;
CC       P31943; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-351590, EBI-742688;
CC       P31943; Q13148: TARDBP; NbExp=6; IntAct=EBI-351590, EBI-372899;
CC       P31943; Q9BXF9: TEKT3; NbExp=3; IntAct=EBI-351590, EBI-8644516;
CC       P31943; Q8WW24: TEKT4; NbExp=3; IntAct=EBI-351590, EBI-750487;
CC       P31943; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-351590, EBI-10180829;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm.
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously.
CC   -!- INDUCTION: Up-regulated in myotonic dystrophy pathophysiology (DM).
CC       {ECO:0000269|PubMed:16946708}.
CC   -!- DOMAIN: Each quasi-RRM repeat bound poly(RG), while only the N-terminal
CC       QRRM bound poly(RC) and poly(RU). None of the repeats bound detectable
CC       amounts of poly(RA).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L22009; AAA91346.1; -; mRNA.
DR   EMBL; CR456778; CAG33059.1; -; mRNA.
DR   EMBL; AK124530; BAG54048.1; -; mRNA.
DR   EMBL; CH471165; EAW53807.1; -; Genomic_DNA.
DR   EMBL; CH471165; EAW53808.1; -; Genomic_DNA.
DR   EMBL; BC001348; AAH01348.1; -; mRNA.
DR   CCDS; CCDS4446.1; -.
DR   PIR; I39358; I39358.
DR   RefSeq; NP_001244222.1; NM_001257293.1.
DR   RefSeq; NP_005511.1; NM_005520.2.
DR   RefSeq; XP_016864904.1; XM_017009415.1.
DR   RefSeq; XP_016864905.1; XM_017009416.1.
DR   RefSeq; XP_016864906.1; XM_017009417.1.
DR   PDB; 2LXU; NMR; -; A=7-111.
DR   PDB; 6DHS; X-ray; 3.50 A; A/B/C/D=10-194.
DR   PDBsum; 2LXU; -.
DR   PDBsum; 6DHS; -.
DR   SMR; P31943; -.
DR   BioGRID; 109428; 1381.
DR   CORUM; P31943; -.
DR   IntAct; P31943; 139.
DR   MINT; P31943; -.
DR   STRING; 9606.ENSP00000349168; -.
DR   ChEMBL; CHEMBL3797013; -.
DR   DrugBank; DB09130; Copper.
DR   iPTMnet; P31943; -.
DR   MetOSite; P31943; -.
DR   PhosphoSitePlus; P31943; -.
DR   SwissPalm; P31943; -.
DR   BioMuta; HNRNPH1; -.
DR   DMDM; 1710632; -.
DR   REPRODUCTION-2DPAGE; IPI00013881; -.
DR   REPRODUCTION-2DPAGE; P31943; -.
DR   EPD; P31943; -.
DR   jPOST; P31943; -.
DR   MassIVE; P31943; -.
DR   MaxQB; P31943; -.
DR   PaxDb; P31943; -.
DR   PeptideAtlas; P31943; -.
DR   PRIDE; P31943; -.
DR   ProteomicsDB; 54814; -.
DR   Antibodypedia; 17692; 299 antibodies.
DR   Ensembl; ENST00000356731; ENSP00000349168; ENSG00000169045.
DR   Ensembl; ENST00000393432; ENSP00000377082; ENSG00000169045.
DR   Ensembl; ENST00000442819; ENSP00000397797; ENSG00000169045.
DR   Ensembl; ENST00000638505; ENSP00000492076; ENSG00000284254.
DR   Ensembl; ENST00000643310; ENSP00000495786; ENSG00000284254.
DR   GeneID; 3187; -.
DR   KEGG; hsa:3187; -.
DR   UCSC; uc003mke.5; human.
DR   CTD; 3187; -.
DR   DisGeNET; 3187; -.
DR   GeneCards; HNRNPH1; -.
DR   HGNC; HGNC:5041; HNRNPH1.
DR   HPA; ENSG00000169045; Low tissue specificity.
DR   MalaCards; HNRNPH1; -.
DR   MIM; 601035; gene.
DR   neXtProt; NX_P31943; -.
DR   OpenTargets; ENSG00000169045; -.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA162391284; -.
DR   VEuPathDB; HostDB:ENSG00000169045.17; -.
DR   eggNOG; KOG4211; Eukaryota.
DR   GeneTree; ENSGT00940000153503; -.
DR   HOGENOM; CLU_032003_1_0_1; -.
DR   InParanoid; P31943; -.
DR   OMA; VEYYTIH; -.
DR   OrthoDB; 603679at2759; -.
DR   PhylomeDB; P31943; -.
DR   TreeFam; TF316157; -.
DR   PathwayCommons; P31943; -.
DR   Reactome; R-HSA-6803529; FGFR2 alternative splicing.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   SIGNOR; P31943; -.
DR   BioGRID-ORCS; 3187; 660 hits in 1010 CRISPR screens.
DR   ChiTaRS; HNRNPH1; human.
DR   GeneWiki; HNRPH1; -.
DR   GenomeRNAi; 3187; -.
DR   Pharos; P31943; Tbio.
DR   PRO; PR:P31943; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P31943; protein.
DR   Bgee; ENSG00000169045; Expressed in left lobe of thyroid gland and 249 other tissues.
DR   ExpressionAtlas; P31943; baseline and differential.
DR   Genevisible; P31943; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0008266; F:poly(U) RNA binding; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB.
DR   GO; GO:0016070; P:RNA metabolic process; TAS:Reactome.
DR   GO; GO:0006396; P:RNA processing; TAS:ProtInc.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR012996; Znf_CHHC.
DR   Pfam; PF00076; RRM_1; 3.
DR   Pfam; PF08080; zf-RNPHF; 1.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Isopeptide bond;
KW   Methylation; mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ribonucleoprotein; RNA-binding; Spliceosome;
KW   Ubl conjugation.
FT   CHAIN           1..449
FT                   /note="Heterogeneous nuclear ribonucleoprotein H"
FT                   /id="PRO_0000367119"
FT   INIT_MET        1
FT                   /note="Removed; alternate"
FT                   /evidence="ECO:0000269|Ref.6, ECO:0000269|Ref.7,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..449
FT                   /note="Heterogeneous nuclear ribonucleoprotein H, N-
FT                   terminally processed"
FT                   /id="PRO_0000081857"
FT   DOMAIN          11..90
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          111..188
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REPEAT          234..249
FT                   /note="1-1"
FT   DOMAIN          289..364
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REPEAT          354..372
FT                   /note="2-1"
FT   REPEAT          374..392
FT                   /note="2-2"
FT   REPEAT          418..433
FT                   /note="1-2"
FT   REGION          234..433
FT                   /note="2 X 16 AA Gly-rich approximate repeats"
FT   REGION          354..392
FT                   /note="2 X 19 AA perfect repeats"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine; in Heterogeneous nuclear
FT                   ribonucleoprotein H; alternate"
FT                   /evidence="ECO:0000269|Ref.6, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         2
FT                   /note="N-acetylmethionine; in Heterogeneous nuclear
FT                   ribonucleoprotein H, N-terminally processed"
FT                   /evidence="ECO:0000269|Ref.6, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         54
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         233
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000269|Ref.6"
FT   MOD_RES         233
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000269|Ref.6, ECO:0007744|PubMed:24129315"
FT   MOD_RES         246
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:15592455"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55795"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        87
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        98
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CONFLICT        188
FT                   /note="R -> G (in Ref. 2; CAG33059)"
FT                   /evidence="ECO:0000305"
FT   STRAND          13..17
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   HELIX           24..30
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   TURN            31..33
FT                   /evidence="ECO:0007744|PDB:2LXU"
FT   TURN            37..41
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          42..47
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          49..59
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          61..65
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   HELIX           66..71
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          75..87
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   HELIX           90..94
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          112..117
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   HELIX           124..130
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          132..134
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          149..151
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          158..160
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   HELIX           162..169
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   STRAND          182..185
FT                   /evidence="ECO:0007744|PDB:6DHS"
FT   HELIX           188..193
FT                   /evidence="ECO:0007744|PDB:6DHS"
SQ   SEQUENCE   449 AA;  49229 MW;  4ECF7A075C2526FF CRC64;
     MMLGTEGGEG FVVKVRGLPW SCSADEVQRF FSDCKIQNGA QGIRFIYTRE GRPSGEAFVE
     LESEDEVKLA LKKDRETMGH RYVEVFKSNN VEMDWVLKHT GPNSPDTAND GFVRLRGLPF
     GCSKEEIVQF FSGLEIVPNG ITLPVDFQGR STGEAFVQFA SQEIAEKALK KHKERIGHRY
     IEIFKSSRAE VRTHYDPPRK LMAMQRPGPY DRPGAGRGYN SIGRGAGFER MRRGAYGGGY
     GGYDDYNGYN DGYGFGSDRF GRDLNYCFSG MSDHRYGDGG STFQSTTGHC VHMRGLPYRA
     TENDIYNFFS PLNPVRVHIE IGPDGRVTGE ADVEFATHED AVAAMSKDKA NMQHRYVELF
     LNSTAGASGG AYEHRYVELF LNSTAGASGG AYGSQMMGGM GLSNQSSYGG PASQQLSGGY
     GGGYGGQSSM SGYDQVLQEN SSDFQSNIA
//
